Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Authorized generics reg coming soon

Executive Summary

CMS plans to issue a proposed reg in the near future on the inclusion of authorized generics in Medicaid "best price" as required by the Deficit Reduction Act, Administrator Mark McClellan tells the Generic Pharmaceutical Association's Annual Policy Conference Sept. 20. However, considering FTC's study on the economic impacts of authorized generic is due out in 2007, McClellan says that CMS would "still value [FTC's] opinion before putting out a final rule." The outgoing Administrator also says CMS will release its revised definition of average manufacturer price this fall. CMS expressed dissatisfaction with HHS IG's lack of detailed guidance in its recommendations for the calculation of the benchmark (1"The Pink Sheet" June 5, 2006, p. 23)...

Related Content

UsernamePublicRestriction

Register

PS047588

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel